Sym004 vs Standard of Care in Subjects With Metastatic Colorectal Cancer

NCT02083653 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

254

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Colorectal Cancer

Interventions

DRUG: Sym004 (12 mg/kg)
DRUG: Sym004 (9/6 mg/kg)
OTHER: Best Supportive Care (BSC)
DRUG: Fluorouracil (5-FU)
DRUG: Capecitabine

Sponsor

Symphogen A/S